<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813433/" ref="ordinalpos=617&amp;ncbi_uid=5489070&amp;link_uid=PMC3813433" image-link="/pmc/articles/PMC3813433/figure/F1/" class="imagepopup">Figure 1. Graphic representation of the effect of fisetin on PI3K/Akt/mTOR <span class="highlight" style="background-color:">signaling</span>.  From: Dietary flavonoid fisetin: A novel dual inhibitor of PI3K/Akt and mTOR for prostate cancer management. </a></div><br /><div class="p4l_captionBody">Simultaneously targeting both PI3K/Akt and mTOR has the potential to inhibit both upstream and downstream signaling in the pathway. Fisetin inhibits the mTOR pathway and keeps the feedback loop in check by also inhibiting the PI3K/Akt pathway and inhibits cell survival and growth.</div></div>